|
UBE2F expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.640600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.386000E-01 |
| Normal-vs-Stage2 |
5.597000E-01 |
| Normal-vs-Stage3 |
1.186570E-01 |
| Normal-vs-Stage4 |
8.342300E-02 |
| Stage1-vs-Stage2 |
4.847600E-01 |
| Stage1-vs-Stage3 |
8.170100E-02 |
| Stage1-vs-Stage4 |
1.073650E-02 |
| Stage2-vs-Stage3 |
5.230200E-01 |
| Stage2-vs-Stage4 |
2.374600E-01 |
| Stage3-vs-Stage4 |
4.494400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.066200E-01 |
| Normal-vs-AfricanAmerican |
4.693000E-01 |
| Normal-vs-Asian |
1.535420E-01 |
| Caucasian-vs-AfricanAmerican |
4.533600E-01 |
| Caucasian-vs-Asian |
1.552230E-01 |
| AfricanAmerican-vs-Asian |
1.907760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.445800E-01 |
| Normal-vs-Female |
9.304200E-02 |
| Male-vs-Female |
2.015800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.011000E-01 |
| Normal-vs-Extreme_Weight |
8.826600E-01 |
| Normal-vs-Obese |
8.781200E-01 |
| Normal-vs-Extreme_Obese |
9.434000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.921400E-01 |
| Normal_Weight-vs-Obese |
7.069400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.292800E-01 |
| Extreme_Weight-vs-Obese |
7.595000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.870200E-01 |
| Obese-vs-Extreme_Obese |
8.933200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.060200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.888000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.251000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.885400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.219800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.036500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.201200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.085000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.793000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.889600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.721000E-01 |
| Normal-VS-Type2 PRCC |
7.148800E-01 |
| Normal-VS-KIRP CIMP |
1.52919999996115E-07 |
| Normal-VS-Unclassified PRCC |
6.417400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.053600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.20430000416505E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
4.413200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.231310E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.232200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.87218999999628E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.339800E-01 |
| Normal-vs-N1 |
1.995500E-02 |
| Normal-vs-N2 |
3.335400E-01 |
| N0-vs-N1 |
5.535800E-03 |
| N0-vs-N2 |
4.340400E-01 |
| N1-vs-N2 |
5.847800E-01 |
|
|
